Spinal cord stimulation may reduce neuropathic pain

Spinal cord stimulation may reduce neuropathic pain

(HealthDay)—Spinal cord stimulation (SCS) effectively reduces chronic pain symptoms in individuals with painful diabetic polyneuropathy (PDPN), according to a study published online Nov. 6 in Diabetes Care.

Maarten van Beek, from Maastricht University Medical Center in the Netherlands, and colleagues performed a prospective multicenter study to examine the long-term effect of SCS on pain ratings, and failure, and complications in 48 patients with PDPN.

The researchers found that after five years, 55 percent of patients had experienced treatment success and 80 percent of patients with a permanent implant still used their SCS device. The median duration of SCS treatment was 60 months. Higher Michigan Diabetic Neuropathy Score was associated with treatment failure during the five-year follow-up (hazard ratio, 3.9).

"SCS is successful in reducing chronic pain symptoms in the lower extremities of patients with PDPN up to five years after initiation of ," the authors write.

The study was funded by Medtronic.

Explore further

Spinal cord stimulation feasible for diabetic neuropathy

More information: Abstract/Full Text (subscription or payment may be required)
Journal information: Diabetes Care

Copyright © 2017 HealthDay. All rights reserved.

Citation: Spinal cord stimulation may reduce neuropathic pain (2017, November 20) retrieved 29 November 2021 from https://medicalxpress.com/news/2017-11-spinal-cord-neuropathic-pain.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors